Date: February 15 – 16, 2019
Location: Nashville, TN
Cost: $595 General; $395 Military; $0 Resident
Description: Join us for a two-day event in the heart of Music City to hear experts in regenerative medicine discuss, “To Graft or Not to Graft.” Topics include:
- Treatment of the Edentulous and Terminal Dentition Maxilla with Bone Grafts and Implants, Daniel B. Spagnoli, DDS, PhD
- Injectable, Compression-resistant Polymer/Ceramic Composite Bone Grafts for Ridge Augmentation, Scott Guelcher, PhD
- Demystifying the Options for the Compromised Maxilla with a Fixed Prosthesis, Edmond Bedrossian, DDS, FACD
- Update on Growth Factors in Oral and Maxillofacial Surgery, Tara Aghaloo, DDS, MD, PhD
- Grafting the Esthetic Zone for Implants, Waldemar Polido, DDS, MS, PhD
- Graftless Options Posterior Maxilla/Mandible (Short Implants), Waldemar Polido, DDS, MS, PhD
- Grafting Ablative Defects – Which Technique Should I Use?, Alan S. Herford, DDS, MD
- Grafting for the Posterior Mandible/Maxilla to Facilitate Implant Placement, George R. Deeb, DDS, MD
Schedule of Events
Speakers & Presentation Abstracts
Speakers and Presentation Abstracts
Tara Aghaloo, DDS, MD, PhD
Update on Growth Factors in Oral and Maxillofacial SurgeryAbstract, Learning Objectives and Bio
Bone augmentation is an extremely common procedure in implant dentistry, where a large number of implant procedures require some form of grafting. With the advent and FDA approval of multiple sources of growth factors, clinicians and patients are requesting and utilizing growth factors in daily practice. Although singular recombinant (rhBMP-2 or rhPDGF-BB) or combined (platelet concentrates) growth factor products are available, do they predictably enhance quality and quantity of bone and soft tissue? Current literature has identified limitations for use of growth factors including cost, consistent and predictable techniques and preparation, long-term studies, and on-label vs. off-label use. This lecture will focus on the state-of-the art and science regarding growth factors for implant dentistry.
- To understand the indications and contraindications of growth factor use for oral and maxillofacial surgery.
- To become familiar with current literature regarding growth factors to enhance both hard and soft tissue healing.
- To understand the limitations of growth factors for oral and maxillofacial reconstruction.
Tara Aghaloo, DDS, MD, PhD
Dr. Tara Aghaloo is Professor in Oral and Maxillofacial Surgery at the UCLA School of Dentistry. She completed her dental training at the University of Missouri in Kansas City, and Oral and Maxillofacial Surgery residency and MD at UCLA. Subsequently, she completed a PhD in oral biology at UCLA.
She is a diplomate of the American Board of Oral and Maxillofacial Surgery. Her clinical practice focuses on bone and soft tissue regeneration for dental implants. She is also active in professional organizations where she is a board member of the Academy of Osseointegration, member of the Osteo Science Foundation Scientific Review Committee, fellow of the ITI, member of the AAOMS CRPTA and Research Committees, and section editor of IJOMI. She lectures nationally and internationally on dental implant surgery and tissue regeneration, including alveolar ridge augmentation, sinus grafting, growth factors, full archrehabilitation, and peri-implantitis.
Edmond Bedrossian, DDS, FACD
Demystifying the Options for the Compromised Maxilla with a Fixed ProsthesisAbstract, Learning Objectives and Bio
In the maxilla, the volumetric loss of bone & soft tissues, enlarged maxillary sinuses, and presence of remaining compromised dentition pose unique surgical and restorative treatment challenges.
The successful fabrication & delivery of fixed implant supported prosthesis is dependent upon a systematic interplay between the surgical and prosthetic treatment planning objectives.
A paradigm shift has taken place as the graftless surgical approach has gained credibility. Reduced treatment time, a single stage surgical reconstructions and immediate loading has resulted in a higher degree of case acceptance.
Grafting procedures to replace the loss of bone and soft tissue are still viable options when the desired final restoration is a fixed prosthesis without pink porcelain. However, the prolonged treatment period with multiple staged procedures carries inherent risks and has to be analyzed carefully in advance and communicated to the patient.
- To discuss treatment planning concepts for the maxilla
- To evaluate algorithm of risks vs. benefits for the Graftless approach
- To understand the algorithm of risks vs. benefits for three-dimensional grafting approach
- To become familiar with prosthetic planning and execution for the maxilla, including materials selection
- To use of planning software (Nobel Clinician) to help in decision making process
- To present decision making algorithms for management of complications
Edmond Bedrossian, DDS, FACD
Dr. Edmond Bedrossian graduated from the University of San Francisco in 1981. He completed his training in 1986 at the University of The Pacific, School of Dentistry and completed a four-year Oral & Maxillofacial Residency training program at the Alameda Medical Center. In addition to private practice, Dr. Bedrossian is the Director of the Surgical Implant training program for both the Oral and Maxillofacial (OMFS) residents at Highland Hospital, Alameda Medical Center and the undergraduate DDS/IDS students at the University of the Pacific Arthur A. Dugoni School of Dentistry.
Since he began teaching in 1990, Dr. Bedrossian has taught in multiple venues and to different levels of students from undergraduates to surgical residents. He conducts a weekly treatment planning conference at both locations. He has also directed the implant program for the AEGD residents. Since 2012, he has offered an annual selective course, “Fundamentals for Understanding Implant Treatment Planning and Techniques”, to the DDS/IDS students in San Francisco.
Dr. Bedrossian is recognized as an expert in the field of dental implants and has given numerous presentations on the subject both nationally and internationally between 2004 and the present. He has also led several long-running study clubs related to this topic. In addition, he has lectured internationally with Professor Brånemark on various topics, especially the rehabilitation of patients with maxillofacial defects.
Dr. Bedrossian is a Diplomate of the American Board of Oral & Maxillofacial Surgeons and a Fellow of the American College of Oral & Maxillofacial Surgeons. Dr. Bedrossian is on the Editorial Board of The International Journal of Oral and Maxillofacial Implants, The Journal of California Dental Association, as well as Clinical Implant Dentistry and Related Research.
Dr. Bedrossian has obtained fellowships in the following organizations: American Dental Association, the American Association of Oral & Maxillofacial Surgeons (1995), American College of Dentists(1993), International College of Oral and Maxillofacial Surgeons (1995), the Academy of Osseoinegration (2011) as well as the distinguished Pierre Fauchard Academy (1989).
George R. Deeb, DDS, MD
Grafting for the Posterior Mandible/Maxilla to Facilitate Implant PlacementAbstract, Learning Objectives and Bio
Clinicians reconstructing patients with dental implants are often faced with inadequate bone volume for conventional implant placement. This lecture will review the procedures available to the oral and maxillofacial surgeon to graft the posterior maxilla and mandible. Topics will include Ridge Preservation, Maxillary Sinus Augmentation (internal and external approach), and Ridge Augmentation (horizontal and vertical) as well as a review of bone grafting principals. Technique videos will be highlighted as well as reviews of the literature and materials utilized for the procedures.
- To review of bone grafting principles
- To discuss ridge preservation, sinus intrusion with molar extraction and maxillary sinus augmentation
- To identify methods of ridge augmentation using particulate graft with a membrane, titanium mesh and interpositional osteotomy
- To compare the differences between horizonal ridge augmentation and horizontal augmentation with cortico-cancellous blocks
Dr. George R. Deeb
Dr. George R. Deeb is an Associate Professor in Department of Oral and Maxillofacial Surgery at Virginia Commonwealth University School of Dentistry, where he serves as the Director of the Graduate and Undergraduate Dental Implant Program.
Dr. Deeb earned his Doctor of Dental Surgery degree at the University of Colorado Health Sciences Center, graduating in 1995. He continued his education at Oregon Health Sciences University, where he graduated with a Doctor of Medicine in 1999 and completed his residency program in Oral and Maxillofacial Surgery in 2001. Prior to joining VCU in 2013, Dr. Deeb practiced in Tucson, Arizona as a partner in a large group practice.
Highly engaged in his profession, Dr. Deeb has published over 25 peer-reviewed articles and book chapters, as well as lectured at national and international meetings. He is a Diplomate of the American Board of Oral and Maxillofacial Surgery, a Fellow of the American College of Surgeons and a Fellow in the Academy of Wilderness Medicine. In his spare time, he is an avid mountaineer and he enjoys glass casting and fusing.
Scott Guelcher, PhD
Injectable, Compression – Resistant Polymer/Ceramic Composite Bone Grafts for Ridge AugmentationAbstract, Learning Objectives and Bio
Mandibular bone defects can lead to significant morbidity if not properly repaired. Current surgical techniques to increase bone volume at deficient defect sites prior to dental implant placement include the use of autografts, distraction osteogenesis, and guided bone regeneration. The local placement of bone grafts augmented with growth factors is a promising treatment option for enhancing the alveolar ridge in patients preceding dental implant surgery. However, these common delivery systems rely upon the principle of guided bone regeneration and require space-maintaining protective polymeric or metal mesh to direct the growth of new bone. We have designed compression-resistant bone grafts augmented with recombinant human morphogenetic protein-2 (rhBMP-2) that promote lateral ridge augmentation without the use of protective mesh.
Compression-resistant bone grafts were evaluated in canine models of vertical and lateral ridge augmentation. Ridge height and width and new bone formation were assessed by mCT, histology, and histomorphometry at 16 weeks. Ridge height and width increased in a dose-responsive manner with increasing rhBMP-2 concentration. Ridge height and width measured for compression-resistant grafts without the use of protective mesh was comparable to that measured for the absorbable collagen sponge carrier with protective mesh (clinical control). Thus, at the same dose of rhBMP-2, an injectable, compression-resistant bone graft resulted in an equivalent volume of new bone formation compared to the clinical control. These findings highlight the potential of compression-resistant bone grafts for ridge augmentation.
- To identify situations where local delivery of growth factors may be preferred for successful augmentation.
- To utilize imaging and histomorphometric techniques for assessing ridge augmentation in preclinical models.
- To gain awareness of new bone grafting technologies that potentially reduce the need for protective metal hardware.
Scott Guelcher, Phd
Scott Guelcher is a Professor of Chemical and Biomolecular Engineering, a Professor of Medicine, and the Director of the Center for Bone Biology at Vanderbilt University in Nashville, TN. Prior to his appointment at Vanderbilt, he was a Senior Associate Scientist at Bayer Corporation and an NIH/NRSA Fellow in the Department of Biomedical Engineering at Carnegie Mellon University in Pittsburgh, PA. Professor Guelcher’s research focuses on the design and development of biomaterials and delivery systems that enhance healing of tissue damaged by trauma or disease. He collaborates with biomedical scientists and clinicians to design, develop, and scale-up new materials for bone and soft tissue regeneration from the bench to the bedside. Current projects include design of injectable tissue grafts for healing bone and skin in challenging environments, including weight-bearing anatomic sites, defects contaminated by bacteria, and large tissue voids resulting from extremity and craniofacial trauma. He also studies how the bone/tumor microenvironment regulates the progression of tumor-induced bone disease and designs new tumor-targeted therapies to block establishment of tumors in bone. Dr. Guelcher is an author on 90 publications and an inventor on 12 patents.
Alan S. Herford, DDS, MD
Grafting Ablative Defects – Which Technique Should I Use?Abstract, Learning Objectives and Bio
Defects requiring reconstruction in the facial region can present challenges. Various techniques including various graft materials are available. Determining the type of missing tissue as well as the size of the defect are important for treatment planning. New technologies such as virtual surgical planning and navigation have improved reconstructive options.
- To describe treatment options for ablative defects
- To discuss benefits of new technologies in improving results
- To determine which defects would benefit from micro vascular tissue flaps
Alan S. Herford, DDS, MD
Alan S. Herford, DDS, MD, is the Chairman of the department of Oral and Maxillofacial Surgery residency program at Loma Linda University School of Dentistry. Dr. Herford is a graduate of Loma Linda University School of Dentistry. His medical degree is from the University of Texas Southwestern Medical School in Dallas. Dr. Herford completed his training in Oral and Maxillofacial Surgery at Parkland Memorial Hospital at the University of Texas Medical Center in Dallas. In 2008 Dr Herford was named the Philip Boyne & Peter Geistlich Endowed Professor in OMS.
Dr. Herford is actively involved in research. He has multiple publications and has presented his original research at both national and international meetings. He was recently awarded the Laskin Award which is given to the authors of the most outstanding article published in the Journal of Oral and Maxillofacial Surgery for that year. Dr Herford is the primary author on numerous peer-reviewed scientific publications on topics ranging from reconstructing skin cancer defects to the use of growth factors to rebuild jaw defects. He has recently authored book chapters on treatment of mandibular fractures, facial flaps, and treatment of soft tissue injuries. His clinical interests are reconstructive surgery and maxillofacial trauma. He is excited about being one of the founding members of Osteo Science Foundation.
Grafting the Esthetic Zone for Implants
Grafting for the Posterior Mandible/Maxilla (Short Implants)Abstract, Learning Objectives and Bio
Grafting the Esthetic Zone for Implants
Numerous details are indispensable to achieve an excellent esthetic result in Implant Dentistry. Among them is the increasing need for bone and soft tissue augmentation in the esthetic area, in both vertical and horizontal aspects. However, these grafts can be applied at different moments of the treatment, according to the clinical situation. Immediate or delayed implant placement, socket preservation procedures and staged grafts and implant placement are the possible choices to rehabilitate the esthetic zone.
- To assess the esthetic risk in patients in need for implants in the esthetic area
- To recognize different moments for implant placement in relation to the extraction in the esthetic zone
- To select clinical indications and techniques for immediate placement and tissue augmentation in the esthetic zone
2nd Presentation following Dr. George R. Deeb – Grafting for the Posterior Mandible/Maxilla (Short Implants)
Several surgical techniques are employed to vertically reconstruct atrophic alveolar bone. However, these ancillary techniques have higher morbidity and are technique sensitive, prone to more complications with less experienced surgeons. The use of short implants is an alternative to adequately restore partially edentulous patients, and its use has grown exponentially on the last years due to great improvements on materials and techniques. Recently, ultra-short implants have been introduced, showing promising results for the rehabilitation of patients with severely resorbed alveolar ridges.
- To list main characteristics of short and ultra-short implants
- To select clinical indications where the use of short implants may be advantageous
- To identify risks and pitfalls on the use of short/ultra-short implants
Waldemar Polido, DDS, MS, PhD
Dr. Polido is Clinical Professor and Director of the Pre-Doctoral Program, Oral and Maxillofacial Surgery, at Indiana University School of Dentistry, Indianapolis, USA; he is also Co-Director of the Center for Implant, Esthetic and Innovative Dentistry, Indiana University School of Dentistry, Indianapolis, USA. Dr. Polido is an Oral and Maxillofacial Surgeon, with MS and PhD degrees from the PUCRS School of Dentistry, Porto Alegre, RS, Brazil. He did his residency at University of Texas, Southwestern Medical Center at Dallas, and is a fellow of the ITI – International Team for Implantology.
Daniel B. Spagnoli, DDS, PhD
Treatment of the Edentulous and Terminal Dentition Maxilla with Bone Grafts and ImplantsAbstract, Learning Objectives and Bio
The presentation will review clinical evaluation, Radiological evaluation and comprehensive treatment planning.
Implant configurations that favor graft or native bone maintenance will be discussed in conjunction with prosthetic principles. The concept of guided implant and guide indexed prosthesis placement to gain accuracy and efficiency will be introduced. Objectives will include methods of Maxillary grafting or enhancement that prepare the Maxilla for a removable or fixed prosthesis. Grafting methods will be correlated with prosthetic options that achieve masticatory efficiency, and esthetic restoration.
- To discuss and present methods of Maxillary grafting or enhancement that prepare the Maxilla for a removable or fixed prosthesis.
- To demonstrate grafting methods that will be correlated with prosthetic options that achieve masticatory efficiency, and esthetic restoration.
- To review clinical evaluation, Radiological evaluation and comprehensive treatment planning.
- To understand implant configurations that favor graft or native bone maintenance in conjunction with prosthetic principles.
- To introduce the concept of guided implant and guide indexed prosthesis placement to gain accuracy and efficiency.
Daniel B. Spagnoli, DDS, PhD
Dr. Spagnoli is author of over 30 articles and book chapters. He has served as section editor of the Cleft Palate-Craniofacial Journal and AAOMFS Knowledge Update. In 2005 and 2006, he co-authored two award-winning papers published in the Journal of Periodontalology and the Journal of Oral and Maxillofacial Surgery. His most recent article, “Dental Implants and the Use of rhBMP-2,” which appeared in the May 2011 issue of Oral and Maxillofacial Surgery Clinics of North America, was reprinted in Dental Clinics of North America that same year. His research, numerous lectures, and continuing education courses are focused on temporomandibular joint disorders and surger, tissue engineering, and preprosthetic surgery. Dr. Spagnoli, who was formerly the Chair at LSU-New Orleans, is now in private practice in North Carolina.
Entertainment: Preston James
A room block has been made at the Hutton Hotel, www.huttonhotel.com.
1808 West End Avenue, Nashville TN 37203
All reservations must be made individually through the hotel’s reservation department by calling (615) 340-9333 or by emailing firstname.lastname@example.org. Reservation requests via email will be responded to within 24 business hours.
- Single rate – $225/night
- Double rate – $225/night
- Triple rate – $245/night
- Quad rate – $265/night
Room rates are exclusive of state and local taxes which are 15.25%, plus a $2.50 state assessment fee.
The cut-off date for the room block is January 24, 2019.
*Please note that you will not receive the discounted rate if you book online.
14.5 CME credits will be provided for full participation in the program.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of PeerPoint Medical Education Institute, LLC and Osteo Science Foundation. The PeerPoint Medical Education Institute, LLC is accredited by the ACCME to provide continuing medical education for physicians.
The PeerPoint Medical Education Institute, LLC designates this live activity for a maximum of 14.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Osteo Science Foundation
Nationally Approved PACE Program Provider for FAGD/MAGD credit.
Approval does not imply acceptance by any regulatory authority, or AGD endorsement.
7/1/18 to 6/30/21
Provider ID: 370582
14.5 CDE credits will be provided for full participation in the program. AGD Code 310